News & Perspective

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Sep 19, 2007

Sep 19, 2007

Biosafety lapses reported at 3 more Texas labs

(CIDRAP News) – Three University of Texas facilities have recently had laboratory accidents with dangerous pathogens, including the agents of anthrax, tularemia, and shigellosis, according to a statement yesterday from the Sunshine Project, a nonprofit group that monitors biodefense research safety.

Apr 25, 2007

Apr 25, 2007

HHS offers plan for defense against biological threats

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently unveiled its plan for developing and buying medical countermeasures against a range of biological, chemical, and other threats, with new anthrax and smallpox vaccines among the near-term priorities.